2023 | First-line nivolumab, paclitaxel, carboplatin, and bevacizumab for advanced non-squamous non-small cell lung cancer: Updated survival analysis of the ONO-4538-52/TASUKI-52 randomized controlled trial | Kim, Hye Ryun; Sugawara, Shunichi; Lee, Jong-Seok; Kang, Jin-Hyoung; Inui, Naoki; Hida, Toyoaki; Lee, Ki Hyeong; Yoshida, Tatsuya; Tanaka, Hiroshi; Yang, Cheng-Ta; Nishio, Makoto; Ohe, Yuichiro; Tamura, Tomohide; Yamamoto, Nobuyuki; CHONG-JEN YU ; Akamatsu, Hiroaki; Takahashi, Shigeru; Nakagawa, Kazuhiko | Cancer medicine | 1 | 0 | |